1. Home
  2. MUJ vs ARCT Comparison

MUJ vs ARCT Comparison

Compare MUJ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackrock MuniHoldings New Jersey Quality Fund Inc.

MUJ

Blackrock MuniHoldings New Jersey Quality Fund Inc.

HOLD

Current Price

$11.55

Market Cap

662.2M

Sector

Finance

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.08

Market Cap

189.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUJ
ARCT
Founded
N/A
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
662.2M
189.9M
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
MUJ
ARCT
Price
$11.55
$7.08
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
$27.70
AVG Volume (30 Days)
89.2K
463.0K
Earning Date
01-01-0001
03-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.50
$5.85
52 Week High
$12.68
$24.14

Technical Indicators

Market Signals
Indicator
MUJ
ARCT
Relative Strength Index (RSI) 20.99 48.18
Support Level $11.56 $6.90
Resistance Level $11.71 $7.88
Average True Range (ATR) 0.12 0.35
MACD -0.09 -0.00
Stochastic Oscillator 0.00 45.88

Price Performance

Historical Comparison
MUJ
ARCT

About MUJ Blackrock MuniHoldings New Jersey Quality Fund Inc.

BlackRock MuniHoldings New Jersey Quality Fund Inc is a non-diversified, closed-end management investment company. Its investment objective is to provide shareholders with current income exempt from U.S. federal income tax and New Jersey personal income taxes. The fund mainly invests in long-term, investment-grade municipal obligations exempt from U.S federal income taxes (except that the interest may be subject to the U.S. federal alternative minimum tax) and New Jersey personal income taxes, with remaining maturities of one year or more at the time of investment. The rest of its managed assets can be invested in securities that are rated below investment grade (or similar instruments), or invested directly in securities or synthetically through the use of derivatives.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: